Is Polyomavirus-Associated Nephropathy More Common in Kidney Transplant Recipients Exposed to Valganciclovir? A Retrospective Single Center Analysis
Transplantation Proceedings · 2023
DOI: 10.1016/j.transproceed.2022.10.063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Rachel Hellemans und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Antwerp University Hospital, Edegem, Belgium; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Wi…. Hauptthemen laut MEDLINE: Polyomavirus, Kidney Transplantation, Kidney Diseases, Cytomegalovirus Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: BK polyomavirus-associated nephropathy (PVAN) is a frequent complication in the early phase after kidney transplantation. The most important risk factor for PVAN is the intensity of immunosuppression. A recent study suggests that exposure to valganciclovir (VGC) could also be a risk factor. METHODS: We performed a retrospective, single-center study to investigate the effect of valganciclovir exposure on the risk for PVAN during the first 100 days post transplant. Cytomegalovirus (CMV) seronegative recipients of a CMV seropositive donor kidney received VGC prophylaxis, whereas CMV seropositive recipients were managed by a pre-emptive CMV strategy. Cox regression analysis was used to identify risk factors for PVAN development with VGC treatment and strength of immunosuppressive therapy as time-dependent variables. RESULTS: A total of 211 adults who received a kidney transplant between 2014 and 2019 were included. Eighteen (9%) developed PVAN. Multivariate regression analysis showed that women have a lower risk of developing PVAN (hazard ratio [HR] 0.08 (confidence interval [CI] 0.01-0.58), P = .013), whereas age was associated with an increased risk for PVAN (HR 1.04 for every additional year [CI 1.00-1.08], P = .029). There was a trend toward a lower risk of PVAN for patients on reduced immunosuppressive therapy (HR 0.44 [CI 0.15-1.24], P = .12). VGC use was not associated with the risk for PVAN (HR 0.99 [CI 0.35-2.78], P = .98). CONCLUSIONS: In our study, VGC exposure was not associated with the risk for PVAN. Our study is the first to reassess in depth the hypothesis that VGC treatment increases the risk of PVAN. The unique strength of this study is the correction for the degree of immunosuppression and the statistical use of time-dependent covariates. This methodological approach can provide a foundation for further studies needed to confirm our findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Antwerp University Hospital, Edegem, Belgium; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Wilrijk, Belgium. Electronic address: rachel.hellemans@uza.be.
- Department of Nephrology, Antwerp University Hospital, Edegem, Belgium.
- Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Wilrijk, Belgium.
- Clinical Trial Center, Antwerp University Hospital, Edegem, Belgium.
- Department of Nephrology, Antwerp University Hospital, Edegem, Belgium; Laboratory of Experimental Medicine and Pediatrics, University of Antwerp, Wilrijk, Belgium.
- Department of Microbiology, Antwerp University Hospital, Edegem, Belgium.
Zitieren
APA
Hellemans, R., Bertels, A., Wijtvliet, V., Wouters, K., Massart, A., Bergs, K., Matheeussen, V., & Abramowicz, D. (2023). Is Polyomavirus-Associated Nephropathy More Common in Kidney Transplant Recipients Exposed to Valganciclovir? A Retrospective Single Center Analysis. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2022.10.063
Vancouver
Hellemans R, Bertels A, Wijtvliet V, Wouters K, Massart A, Bergs K, et al. Is Polyomavirus-Associated Nephropathy More Common in Kidney Transplant Recipients Exposed to Valganciclovir? A Retrospective Single Center Analysis. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2022.10.063
BibTeX
@article{Hellemans2023,
author = {Hellemans, Rachel and Bertels, Andrea and Wijtvliet, Veerle and Wouters, Kristien and Massart, Annick and Bergs, Kristof and Matheeussen, Veerle and Abramowicz, Daniel},
title = {Is Polyomavirus-Associated Nephropathy More Common in Kidney Transplant Recipients Exposed to Valganciclovir? A Retrospective Single Center Analysis},
journal = {Transplantation Proceedings},
year = {2023},
doi = {10.1016/j.transproceed.2022.10.063}
}
EUVIMED